CBD Intrinsic Value

Intrinsic Value of CBD Overview

Key Highlights:
As of May 17, 2024 CBD Relative Value is $3.9, which is undervalued by 613.1%, compared to current share price of $0.5.
As of May 17, 2024 CBD DCF Value is N/A, which is undervalued by N/A, compared to current share price of $0.5.
Methodology
Price per share, $
Current share price
0.5
DCF value
not available

CBD Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

CBD Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
0.4x (as of May 17, 2024)
EV/Gross Profit
1.5x (as of May 17, 2024)
EV/EBIT
97.2x (as of May 17, 2024)
EV/EBITDA
5.8x (as of May 17, 2024)
EV/FCF
28.2x (as of May 17, 2024)
EV/OCF
6.1x (as of May 17, 2024)
P/Revenue
0.0x (as of May 17, 2024)
P/Gross Profit
0.2x (as of May 17, 2024)
P/EBIT
12.2x (as of May 17, 2024)
P/EBITDA
0.7x (as of May 17, 2024)
P/FCF
3.5x (as of May 17, 2024)
P/OCF
0.8x (as of May 17, 2024)
P/E
(2.5x) (as of May 17, 2024)
P/BV
0.2x (as of May 17, 2024)
PEG 1Y
0.0x (as of May 17, 2024)

CBD DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'19 ActualDec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 EstimateDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 Terminal
% growth
28,838.0
(41.6%)
51,253.0
77.7%
16,298.0
(68.2%)
17,321.0
6.3%
19,250.0
11.1%
25,480.5
32.4%
26,557.1
4.2%
26,745.6
0.7%
33,105.5
23.8%
39,971.4
20.7%
47,046.1
17.7%
53,942.8
14.7%
60,210.8
11.6%
65,376.8
8.6%
68,998.6
5.5%
70,723.6
2.5%
723.0
2.5%
2,228.0
4.3%
317.0
1.9%
(68.0)
(0.4%)
97.0
0.5%
674.1
2.6%
702.6
2.6%
707.6
2.6%
875.8
2.6%
1,057.5
2.6%
1,244.7
2.6%
1,427.1
2.6%
1,592.9
2.6%
1,729.6
2.6%
1,825.4
2.6%
1,871.1
2.6%
NOPAT
% effective tax rate
909.6
3.2%
1,452.1
2.8%
720.2
4.4%
(91.5)
(0.5%)
(25.1)
(0.1%)
(174.6)
(0.7%)
(182.0)
(0.7%)
(183.3)
(0.7%)
(226.9)
(0.7%)
(273.9)
(0.7%)
(322.4)
(0.7%)
(369.7)
(0.7%)
(412.6)
(0.7%)
(448.0)
(0.7%)
(472.9)
(0.7%)
(484.7)
(0.7%)
% of revenue
1,555.0
5.4%
2,501.0
4.9%
2,059.0
12.6%
1,852.0
10.7%
1,136.0
5.9%
2,482.4
9.7%
2,587.3
9.7%
2,605.6
9.7%
3,225.2
9.7%
3,894.1
9.7%
4,583.4
9.7%
5,255.3
9.7%
5,865.9
9.7%
6,369.2
9.7%
6,722.1
9.7%
6,890.1
9.7%
% of revenue
(2,782.0)
(9.6%)
(2,490.0)
(4.9%)
(1,267.0)
(7.8%)
(1,626.0)
(9.4%)
(1,014.0)
(5.3%)
(1,905.0)
(7.5%)
(1,985.5)
(7.5%)
(1,999.6)
(7.5%)
(2,475.1)
(7.5%)
(2,988.4)
(7.5%)
(3,517.3)
(7.5%)
(4,032.9)
(7.5%)
(4,501.6)
(7.5%)
(4,887.8)
(7.5%)
(5,158.6)
(7.5%)
(5,287.5)
(7.5%)
(1,955.0)
(6.8%)
630.0
1.2%
606.0
3.7%
(2,463.0)
(14.2%)
(785.0)
(4.1%)
(1,238.3)
(4.9%)
(1,290.6)
(4.9%)
(1,299.8)
(4.9%)
(1,608.9)
(4.9%)
(1,942.5)
(4.9%)
(2,286.3)
(4.9%)
(2,621.5)
(4.9%)
(2,926.1)
(4.9%)
(3,177.2)
(4.9%)
(3,353.2)
(4.9%)
(3,437.0)
(4.9%)
Free Cash Flow to Firm (FCFF)
% of revenue
(2,272.4)
(7.9%)
2,093.1
4.1%
2,118.2
13.0%
(2,328.5)
(13.4%)
(688.1)
(3.6%)
(835.5)
(3.3%)
(870.8)
(3.3%)
(877.0)
(3.3%)
(1,085.6)
(3.3%)
(1,310.7)
(3.3%)
(1,542.7)
(3.3%)
(1,768.8)
(3.3%)
(1,974.4)
(3.3%)
(2,143.8)
(3.3%)
(2,262.5)
(3.3%)
(2,319.1)
(3.3%)
% of FCFF used in calculation
62.5%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Discount period
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
9.50
Discount factor
0.98
0.94
0.90
0.86
0.83
0.79
0.76
0.73
0.70
0.67
Discounted FCFF (DFCFF)

CBD DCF Value

DCF Value Calculation

as of May 17, 2024
Sum of DFCFF
% share of EV
N/A
30.0%
Terminal Value (TV)
N/A
Discounted TV
% share of EV
N/A
70.0%
Total Debt
9,574.0M
Shares outstanding
313.0M
FX rate
N/A
100% overvalued

Equity Value Bridge

CBD Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

CBD Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Sep 30, 2024
Long-Term growth rate
2.5%
FX rate
0.2
Last share price
0.5
Implied FCF growth 1-10Y
(16.9%)

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with CBD Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$169.1M
$1,349.7M
$3.9
617.3% undervalued
N/A
$3.9
617.3% undervalued
$42.6
7,792.8% undervalued
$12.7
2,254.9% undervalued
84.2%
15.8%
(16.9%)
(100.0%)
$79.3B
$70.9B
$50.3
59.9% overvalued
N/A
$50.3
59.9% overvalued
$40.0
68.1% overvalued
$40.9
67.4% overvalued
29.1%
70.9%
4.6%
4.8%
$5,872.5M
$5,184.2M
$324.9
11.2% overvalued
N/A
$324.9
11.2% overvalued
Negative
280.2% overvalued
Negative
319.8% overvalued
296.1%
(196.1%)
8.2%
0.0%
$4,800.4M
$4,716.6M
$739.2
199.3% undervalued
$845.2
242.0% undervalued
$633.2
156.4% undervalued
$523.6
112.0% undervalued
$272.8
10.5% undervalued
136.3%
(36.3%)
(12.4%)
(5.3%)
$4,002.8M
$4,632.8M
$24.3
0.2% undervalued
N/A
$24.3
0.2% undervalued
$23.8
1.8% overvalued
$37.4
54.4% undervalued
(5,392.6%)
5,492.6%
(53.2%)
(53.2%)
$3,816.9M
$9,327.9M
$23.1
68.8% undervalued
N/A
$23.1
68.8% undervalued
$274.9
1,905.0% undervalued
$85.9
526.5% undervalued
211.4%
(111.4%)
(7.3%)
(11.2%)
$2,204.8M
$4,021.7M
$161.1
341.2% undervalued
$109.8
201.0% undervalued
$212.5
481.8% undervalued
$598.5
1,538.7% undervalued
N/A
(177.2%)
277.2%
(100.0%)
(8.3%)
$1,021.8M
$3,777.8M
$29.2
219.4% undervalued
N/A
$29.2
219.4% undervalued
$22.8
149.2% undervalued
$24.5
168.3% undervalued
176.4%
(76.4%)
(0.0%)
(33.4%)
$833.7M
$586.8M
$16.4
65.2% undervalued
$8.6
13.0% overvalued
$24.2
143.6% undervalued
$40.4
306.3% undervalued
$18.9
90.2% undervalued
69.3%
30.7%
(1.4%)
(2.4%)
$562.9M
$1,257.1M
$37.6
982.3% undervalued
$65.2
1,780.0% undervalued
$9.9
184.8% undervalued
$23.7
583.9% undervalued
$13.3
282.4% undervalued
155.3%
(55.3%)
(100.0%)
(16.8%)
$413.4M
($274.9M)
$647.8
2,387.8% undervalued
N/A
$647.8
2,387.8% undervalued
N/A
N/A
N/A
N/A
N/A
N/A

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.

FAQ

What is the DCF value of Companhia Brasileira de Distribuição (CBD)?

As of today, DCF Value of Companhia Brasileira de Distribuição is $0.0, which is undervalued by 0.0%, compared to the current market share price of $0.5

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating Companhia Brasileira de Distribuição future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $0.0B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 0 to determine DCF Value of $0.0

What is the Relative value of Companhia Brasileira de Distribuição (CBD)?

As of today, Relative Value of Companhia Brasileira de Distribuição is $3.9, which is undervalued by 617.3%, compared to the current market share price of $0.5

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to Companhia Brasileira de Distribuição financials to determine Relative Value of $3.9

What is Companhia Brasileira de Distribuição (CBD) discount rate?

Companhia Brasileira de Distribuição current Cost of Equity is 14.2%, while its WACC stands at 4.3%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for Companhia Brasileira de Distribuição (CBD) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 14.2% = 4.4% + 1.2 x 4.6%

How is WACC for Companhia Brasileira de Distribuição (CBD) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company's entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 4.3% = 14.2% x 91.1% + 3.4% x (1 - 2.3%) x 8.9%